MLIC
DGX icon

Mandatum Life Insurance Company’s Quest Diagnostics DGX Stock Holding History

Mandatum Life Insurance Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,916
Closed -$681K – 157
2017
Q4 		$681K Hold
6,916
– – 0.11% 110
2017
Q3 		$648K Buy
6,916
+2,253
+48% +$239K 0.09% 111
2017
Q2 		$518K Hold
4,663
– – 0.07% 121
2017
Q1 		$458K Hold
4,663
– – 0.06% 147
2016
Q4 		$429K Hold
4,663
– – 0.06% 153
2016
Q3 		$395K Hold
4,663
– – 0.05% 150
2016
Q2 		$380K Hold
4,663
– – 0.05% 155
2016
Q1 		$333K Hold
4,663
– – 0.04% 162
2015
Q4 		$332K Buy
+4,663
New +$313K 0.05% 149

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mandatum Life Insurance Company's DGX Position: Q1 2018 in Review

Mandatum Life Insurance Company sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 6,916 shares — an estimated $681K sold.

Mandatum Life Insurance Company first reported a position in DGX in Q4 2015 and held it in 9 quarters. The position peaked at $681K in Q4 2017. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • Mandatum Life Insurance Company reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 6,916 Quest Diagnostics shares in Q1 2018, an estimated $681K.
  • Mandatum Life Insurance Company first reported a position in Quest Diagnostics in Q4 2015 and held it in 9 quarters.
  • Mandatum Life Insurance Company's Quest Diagnostics position peaked at $681K in Q4 2017.
  • 653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2018, filed 4 May 2018.